Weight Loss Drug – Wegovy

sfg-2026
ForumIAS LATEST
      1. SFG 2027 Level-1 starts 21 Dec. 2026 at 7 AM | Entrance Test on 22 Nov. at 9:30 AM Click Here to know more →
      2. Interview Guidance initiative by ForumIAS – UPSC CSE 2026 Click Here to know more →
      3. FRC 2027: SFG Residential program | accepting application for Tranche-2 Click Here to know more →

News: Danish drugmaker Novo Nordisk has launched its weight loss drug Wegovy as a once-a-week injection in India.

About Weight Loss Drug – Wegovy

Source – ABC News
  • It is a prescription weight loss drug developed by Danish pharmaceutical company Novo Nordisk.
  • It contains semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes but found to be highly effective for weight loss.
  • It is administered as a once-weekly injection using a convenient pen device (FlexiPen or FlexTouch).
  • The drug is approved by Central Drugs Standard Control Organisation, (CDSCO) in India strictly for obesity management and not for diabetes.

Working

  • It is made of semaglutide, a GLP 1A receptor agonist, which mimics the naturally occurring hormone GLP-1, responsible for regulating blood sugar, reducing appetite and slowing down gastric emptying.
  • It makes a person feel fuller for longer and eat less.

Other Weight Loss Drugs

  • Ozempic is used more for diabetes management. The main difference between the two is the dose.
  • Rybelsus is an oral pill for the same.
  • Mounjaro is made up of tirzepatide, which mimics the function of natural hormones GIP and GLP-1.
    • It has a double effect, of increasing insulin secretion in response to food intake and improving glucose control and weight loss.
Print Friendly and PDF
Blog
Academy
Community